Disease burden of hematological malignancies worldwide, in China and in the United States based on the GLOBOCAN 2022 and Global Burden of Disease 2021 data

Abstract. Background:. Hematological malignancies are a heterogeneous group of diseases caused by disruptions in normal hematopoietic function. This study aimed to evaluate the global burden of hematological malignancies, including Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), multiple myeloma...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Minghao Lin, Wei Sun, Xiaojun Huang, Xiangyu Zhao, Sihan Zhou, Xiuyuan Hao
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wolters Kluwer 2026-04-01
Ráidu:	Chinese Medical Journal
Liŋkkat:	http://journals.lww.com/10.1097/CM9.0000000000003969
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!